优泌林70/30联合二甲双胍片治疗2型糖尿病的临床观察

Clinical Observation of Type 2 Diabetes Humulin 70/30 Joint Metformin Therapy

目的研究重组人胰岛素(优泌林)联合二甲双胍片治疗2型糖尿病的方法。方法将60例确诊为2型糖尿病进行治疗。应用重组人胰岛素(优泌林)并口服二甲双胍,每次0.25 mg每日3次。优泌林70/30初始剂量为10 u/d,分2次注射,应用胰岛素笔进行注射,精确掌握注射药物剂量。1周为剂量调整期,每次调整2 u进行治疗。二甲双胍,每次0.25 mg每日3次。结果所有患者经适当调整药物剂量治疗后,均已达到治疗目标。FBG<7.0 mmol/L、2hPBG<10.0 mmol/L、HbAlc<7%,并2个月检测肝功能、肾功能。并注意患者体质指数的变化。结论 2型糖尿病患者适宜用此方案治疗。

Objective To study the recombinant human insulin metformin（Humulin） method for the treatment of type 2 diabetes. Methods 60 patients diagnosed with type 2 diabetes treatment. Application of recombinant human insulin（Humulin）and oral metformin, each 0.25 mg three times a day. Humulin 70/30 initial dose of 10 u/day, divided 2 injections, injecting insulin pen, accurately injecting drug doses. 1 week for dose adjustment and adjust each 2 u for treatment. Metformin, each 0.25 mg three times a day. Results All patients after treatment with adjust drug doses, treatment goals has been achieved. FBG〈7.0 mmol/L, 2 hPBG〈 10.0 mmol/L, HbAtc〈7%, in February and detection of liver and kidney function. And pay attention to the patient changes in body mass index. Conclusion Patients with type 2 diabetes is suitable for treatment with this solution.